New devices and guidance available for management of COPD and asthma

Hdl Handle:
http://hdl.handle.net/10147/558872
Title:
New devices and guidance available for management of COPD and asthma
Authors:
Ging, Patricia; Conroy, Leah; Johnston, Grainne; Kehoe, Brona; Brown, Jennifer
Publisher:
Nursing in General Practice
Journal:
Nursing in General Practice
Issue Date:
Jan-2015
URI:
http://hdl.handle.net/10147/558872
Abstract:
Nurses will have noticed a recent explosion in the number of new inhalers becoming available for the management of asthma and even more so for COPD. There are new devices and new drugs to become familiar with (as well as expanded indications for some existing agents) and nurses may have already observed changes in prescribing patterns. This article will discuss the evolving place of these new agents in the context of limited health budgets, updated GOLD guideline s1 and the Health Service Executive (HSE) Medicines Management Programme (MMP) 2, 3 as well as an overview of the newer inhalers available on the Irish market. The HSE spent in excess of €107 million 2 on inhaled therapies in 2013 so it is no surprise that the MMP has identifi ed inhaled therapies as a priority with regard to cost containment and rationalisation
Item Type:
Article
Language:
en
Keywords:
ASTHMA; CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Full metadata record

DC FieldValue Language
dc.contributor.authorGing, Patriciaen
dc.contributor.authorConroy, Leahen
dc.contributor.authorJohnston, Grainneen
dc.contributor.authorKehoe, Bronaen
dc.contributor.authorBrown, Jenniferen
dc.date.accessioned2015-07-06T10:29:33Zen
dc.date.available2015-07-06T10:29:33Zen
dc.date.issued2015-01en
dc.identifier.urihttp://hdl.handle.net/10147/558872en
dc.description.abstractNurses will have noticed a recent explosion in the number of new inhalers becoming available for the management of asthma and even more so for COPD. There are new devices and new drugs to become familiar with (as well as expanded indications for some existing agents) and nurses may have already observed changes in prescribing patterns. This article will discuss the evolving place of these new agents in the context of limited health budgets, updated GOLD guideline s1 and the Health Service Executive (HSE) Medicines Management Programme (MMP) 2, 3 as well as an overview of the newer inhalers available on the Irish market. The HSE spent in excess of €107 million 2 on inhaled therapies in 2013 so it is no surprise that the MMP has identifi ed inhaled therapies as a priority with regard to cost containment and rationalisationen
dc.language.isoenen
dc.publisherNursing in General Practiceen
dc.subjectASTHMAen
dc.subjectCHRONIC OBSTRUCTIVE PULMONARY DISEASEen
dc.titleNew devices and guidance available for management of COPD and asthmaen
dc.typeArticleen
dc.identifier.journalNursing in General Practiceen
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.